Prof. Esra Baskin, Turkey Invited Speaker
Immunosuppression in kidney Tx for children

Dr. Ebru Sevinc Ok, Turkey
Results of MMF+EVO combination in drug switching after kidney transplantation.

Andrew Santeusanio, United States
Comparison of actual versus ideal body weight based dosing of anti-thymocyte globulin in kidney transplant recipients

Dr. Hay Me Me, United States
Differences in High and Low Dose Belatacept Conversion Effects in Kidney Transplant Patients

Dr. Sushrut Gupta, India
CYP3A5 Polymorphism in Kidney Transplantation: Individualizing Tacrolimus Dosing

Dr. Huseyin Akilli, Turkey
Atypical cervical cytology in solid organ transplantation patients: 20 years of experience in a single center

Alain Assounga, South Africa
High intra patient variability (IPV) of serum tacrolimus is associated with a worsening serum creatinine in tkidney transplant patients attening Inkosi Albert Luthuli Central Hospital, Durban, South Africa.

Dr. Sergio DJ. Salcedo Herrera Sr., Colombia
Correlating Tacrolimus Levels with Dose Formulation: Implications for Toxicity and Renal Graft Rejection in a cohort of kidney Transplant Recipients with Steroid-free maintenance immunosuppression.

Mrs. Ariunaa Ari Altangerel, Mongolia
Identification of cytokine profiles in blood samples from kidney transplant recipients